Press releases
2010
11-18-2010
curasan AG receives approval for Cerasorb® M ORTHO in Canada
Kleinostheim, Germany, 18th November 2010 – curasan AG, listed in the General Standard (ISIN: DE 000 549 453 8) has received the certification for the synthetic bone regeneration material Cerasorb® M ORTHO from the Canadian authorities, Health Canada ...
10-21-2010
curasan AG: Bioactive bone regeneration material approved for sale in Europe
Kleinostheim, Germany, 21st October 2010 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8) has received European approval for its new granular bone regeneration material Ceracell® ...
07-27-2010
curasan AG scouts for sales partners for ATR®
Kleinostheim, Germany, 27th July 2010 – curasan AG, listed in the General Standard of the Frankfurt Stock Exchange (ISIN: DE 000 549 453 8), has commenced with the pre-marketing activities for the launch of its new product ATR® (Advanced Tissue Regeneration)...
05-25-2010
curasan AG: cooperation agreement for new product line
Kleinostheim, Germany, 25th May 2010 – curasan AG, listed in the General Standard of the Frankfurt Stock Exchange (ISIN: DE 000 549 453 8), has concluded a contract with Matricel GmbH, Herzogenrath, which secures exclusive rights for both companies over a jointly developed new product line...
05-06-2010
curasan AG: 2009 fiscal year above expectations
Kleinostheim, Germany, 6th May 2010 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), was able to achieve an annual surplus of 0.2 million Euro in the fiscal year 2009 ...
04-28-2010
curasan AG: One million units of Cerasorb® produced
Kleinostheim, Germany, 28th April 2010 – The employees of curasan AG awaited the recently produced batch of Cerasorb® M with particular excitement – because amongst this batch was the one millionth bottle ready for sale...
02-18-2010
curasan AG: New US subsidiary for orthopaedics
Kleinostheim, Germany, 18th February 2010 – curasan AG, listed in the General Standard of the Deutsche Börse AG (ISIN: DE 000 549 453 8), is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States ...